TW201440780A - Antrodia cinnamomea fermentation composition and uses thereof - Google Patents

Antrodia cinnamomea fermentation composition and uses thereof Download PDF

Info

Publication number
TW201440780A
TW201440780A TW102115290A TW102115290A TW201440780A TW 201440780 A TW201440780 A TW 201440780A TW 102115290 A TW102115290 A TW 102115290A TW 102115290 A TW102115290 A TW 102115290A TW 201440780 A TW201440780 A TW 201440780A
Authority
TW
Taiwan
Prior art keywords
extract
minutes
composition
tea
antrodia camphorata
Prior art date
Application number
TW102115290A
Other languages
Chinese (zh)
Inventor
Ching-Shan Yang
Chi-Tien Huang
Jing-Deng Lan
Original Assignee
Keep Growth Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keep Growth Biotech Co Ltd filed Critical Keep Growth Biotech Co Ltd
Priority to TW102115290A priority Critical patent/TW201440780A/en
Publication of TW201440780A publication Critical patent/TW201440780A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an Antrodia camphorate fermentation composition comprising A. cinnamomea fermentation broth and tea leaf extract. It is shown that the composition has the pharmaceutical effects of anti-tumor and immunity enhancement by quantum resonance spectrometry (QRS) measurement.

Description

牛樟芝醱酵組合物及其應用 Antrodia camphorata fermentation broth and its application

本發明係關於一種牛樟芝醱酵組合物。詳言之,本發明係關於抗腫瘤及提升免疫功能之牛樟芝醱酵組合物。 The present invention relates to a burdock fermented composition. In particular, the present invention relates to an anti-tumor and immune-enhancing burdock fermented composition.

生長在台灣特有保育樹種台灣牛樟(Cinnamomum kanehirai Hayata)腐朽之心材內壁的牛樟芝,又稱為樟芝、牛樟菇,屬於擔子菌亞門、同擔子菌綱、無褶菌目、多孔菌科、薄孔菌屬,具黃樟香氣味,其學名可為Antrodia cinnamomeaGanoderma comphoratumAntrodia comphoratum。牛樟芝已知富含多種對人體有益之活性成分,諸如三萜類化合物、β-D-葡聚醣、固醇類、超氧岐化酵素、腺苷、蛋白質、維生素B群、菸鹼酸及微量元素如鈣、磷、鍺、鋅等,而具有增強免疫、抗癌、抗氧化、抗發炎、護肝等養生保健功效。 Antrodia camphorata, also known as Antrodia camphorata, and Astragalus membranaceus, which grows on the inner wall of Taiwan's endemic tree species Cinnamomum kanehirai Hayata . It belongs to Basidiomycetes, the genus Basidiomycetes, Pleurotus ostreatus, Polyporus It has a scent of yellow musk and its scientific name can be Antrodia cinnamomea , Ganoderma comphoratum or Antrodia comphoratum . Antrodia camphora is known to be rich in a variety of active ingredients beneficial to the human body, such as triterpenoids, β-D-glucan, sterols, superoxide dismutase, adenosine, protein, vitamin B group, niacin and Trace elements such as calcium, phosphorus, strontium, zinc, etc., have the effects of enhancing immunity, anti-cancer, anti-oxidation, anti-inflammatory, and protecting the liver.

雖牛樟芝具有前述多重功效,但因牛樟芝只生長在台灣高海拔之牛樟樹上,經人為濫採後,野生牛樟芝資源已日益枯竭,因此近年來已逐漸改由利用傳統培植方式獲得牛樟芝子實體,或利用醱酵培養方式獲得牛樟芝菌絲體或醱酵物,以做為保健產品。 Although Antrodia camphorata has the above-mentioned multiple functions, it has been grown on Taiwan's high-altitude burdock tree. After artificial indiscriminate mining, the wild Antrodia camphorata resources have been increasingly exhausted. Therefore, in recent years, the traditional cultivation method has been used to obtain the Antrodia camphorata fruit body. Or use the fermentation method to obtain the mycelium or mash of A. glabrata as a health care product.

舉例言之,依據中華民國專利第I226370號「樟芝(Antrodia camphorata)分離株用以製造該分離株之培養物的方法以及藉由該方法所得之產物」,該專利所揭示之牛樟芝菌株在特定液態培養條件 下,其醱酵物具備優於其它牛樟芝菌株之抑制癌細胞活性,另一方面,以此醱酵物進行應用性之研究,亦發現該牛樟芝醱酵物能有效降低內皮細胞之氧化傷害(J Ethnopharmacol.,118:237-245,2008)、降低巨噬細胞之發炎反應(Int Immunopharmacol.,5:1914-192,2005)、在異種移殖人類乳癌細胞試驗中具備顯著抑制腫瘤增生之效果(Food Chem Toxicol.,46:2680-2688,2008)及保護因四氯化碳造成之肝損傷(World J Gastroenterol.,12:2369-2374,2006)。另一方面,牛樟芝菌產出之液態醱酵物活性成分較單純且功效明確,經研究指出其中含有多種奎寧類成分(J Chilean Chemical Society.,52:1338-1340,2007),其在動物實驗及細胞測試的結果顯示具有抗發炎(Int Immunopharmacol.,5:1914-1925,2005)、抑制腫瘤細胞增生(J Ethnopharmacol.,100:158-167,2005)。 For example, according to the method of the Chinese Patent No. I226370 " Antrodia camphorata isolate for producing a culture of the isolate and the product obtained by the method", the strain of the Antrodia camphorata disclosed in the patent is specific Under liquid culture conditions, the mash has better anti-cancer activity than other strains of Antrodia camphorata. On the other hand, the application of this mash is also found to effectively reduce the oxidative damage of endothelial cells. Ethnopharmacol., 118: 237-245, 2008), reduces the inflammatory response of macrophages (Int Immunopharmacol., 5: 1914-192, 2005), and has the effect of significantly inhibiting tumor proliferation in heterologous transplanted human breast cancer cells ( Food Chem Toxicol., 46: 2680-2688, 2008) and protection of liver damage caused by carbon tetrachloride (World J Gastroenterol., 12: 2369-2374, 2006). On the other hand, the liquid lysate active ingredient produced by Antrodia camphorata is simpler and more effective, and it has been pointed out that it contains a variety of quinine-based ingredients (J Chilean Chemical Society., 52: 1338-1340, 2007), which is used in animal experiments. The results of the cell test showed anti-inflammatory (Int Immunopharmacol., 5: 1914-1925, 2005), inhibition of tumor cell proliferation (J Ethnopharmacol., 100: 158-167, 2005).

然而牛樟芝醱酵物之口感並不為消費者所喜愛,其具有苦味、酸味或澀味,飲後並殘留之不愉快之餘味,市面上牛樟芝飲料大多與中草藥結合,許多療效極佳之原料其氣味苦澀,其口感更不適於經常性飲用,使消費者之飲用意願降低,而無法享受其療效。 However, the taste of the burdock is not popular with consumers. It has bitterness, sourness or astringency. After drinking, it has an unpleasant aftertaste. Most of the burdock drinks on the market are combined with Chinese herbal medicines. Many of the ingredients with excellent curative taste are bitter. The taste is even less suitable for regular drinking, so that consumers' willingness to drink is reduced, and their efficacy cannot be enjoyed.

茶是廣受歡迎的飲料之一,泛指可用於泡茶的常綠灌木茶樹的葉子泡製的飲料,其飲用方法亦十分多樣。隨著近年來健康食品之日益風行,茶之保健功能倍受關注。自茶樹摘下的葉子稱之茶菁,依醱酵程度不同可區分為不同種類,如綠茶屬不醱酵茶;烏龍茶屬半醱酵茶;紅茶屬全醱酵茶。茶菁中約40%至約60%之可溶性固形物為類黃酮(flavonoids)等多酚類化合物,具特殊的生理功能,是茶湯滋味、香氣及色澤的重要來源。茶中的類黃酮化合物又可分成黃烷醇類(flavanols)、黃酮醇類(flavonols)、酚酸(phenolic acids)、縮酚(depsides)和其他多酚類等,其中黃烷醇類中兒茶素類(catechins),是茶菁中主要的多酚類化合物,約占多酚類總量約75%至約80%,其中 表沒食子兒茶素沒食子酸酯(epigallocatechin gallate,EGCG)之含量最多,約占總兒茶素約50%,證實是抗氧化活性最強之兒茶素,具減重、抗腫瘤、降血脂、降血壓、增強免疫力等功效。 Tea is one of the most popular beverages. It refers to the beverages made from the leaves of evergreen shrub tea trees that can be used for making tea. The drinking methods are also very diverse. With the increasing popularity of healthy foods in recent years, the health care function of tea has received much attention. The tea leaves picked from the tea tree can be divided into different types depending on the degree of fermentation. For example, green tea is not a yeast tea; oolong tea is a semi-fermented yeast tea; black tea is a full-fermented yeast tea. About 40% to about 60% of the soluble solids in the tea phthalocyanine are polyphenolic compounds such as flavonoids, which have special physiological functions and are an important source of taste, aroma and color of the tea soup. Flavonoids in tea can be further divided into flavanols, flavonols, phenolic acids, depsides and other polyphenols, among which flavanols The catechins are the main polyphenolic compounds in the tea phthalocyanine, accounting for about 75% to about 80% of the total polyphenols. Epigallocatechin gallate (EGCG) is the most abundant, accounting for about 50% of total catechins. It is confirmed to be the most potent catechin with antioxidant activity, with weight loss and anti-tumor. Reduce blood fat, lower blood pressure, enhance immunity and other effects.

現今茶飲料雖應用廣泛,但消費者對於機能性之茶飲料需求仍持續增加,且為因應口味多樣化之趨勢,開發新茶飲料仍為飲食品領域之重要課題。 Although tea beverages are widely used today, consumer demand for functional tea beverages continues to increase, and in response to the trend of diversified tastes, the development of new tea beverages remains an important issue in the food and beverage sector.

綜上所述,本領域中亟需發展兼顧飲用口味及療效之飲品原料,使牛樟芝及茶之應用更加廣泛。 In summary, there is an urgent need in the art to develop beverage materials that take into consideration the taste and efficacy of the beverage, and to make the application of Antrodia camphorata and tea more extensive.

本發明提供牛樟芝醱酵組合物,可排除牛樟芝發酵物之苦味、酸味或澀味後所殘留之不愉快餘味,明顯改善牛樟芝醱酵物之口感,適合日常飲用,且其抗腫瘤及免疫提升功能具有加成性之增加,亦可拓展成為機能性茶飲品及醫藥品。 The invention provides a burdock and yoghurt fermentation composition, which can eliminate the unpleasant aftertaste remaining after the bitterness, sourness or astringency of the fermentation product of the burdock, and obviously improve the taste of the burdock medicinal glutinous protein, is suitable for daily drinking, and has anti-tumor and immune lifting functions. The increase in adultness can also be expanded into functional tea drinks and pharmaceuticals.

本發明係提供一種組合物,其包含:牛樟芝醱酵物;及茶葉萃取物。 The present invention provides a composition comprising: Antrodia camphorata; and a tea extract.

本發明另提供一種前述組合物之用途,其係用於製備治療腫瘤之藥物。 The invention further provides the use of a composition as described above for the preparation of a medicament for the treatment of a tumor.

本發明亦提供一種前述組合物之用途,其係用於製備提升免疫力之藥物。 The invention also provides the use of a composition as described above for the preparation of a medicament for boosting immunity.

圖1顯示牛樟芝醱酵物之高壓液相層析圖。 Figure 1 shows a high pressure liquid chromatogram of the extract of Antrodia camphorata.

本發明係提供一種組合物,其包含:牛樟芝醱酵物;及茶葉萃取物。 The present invention provides a composition comprising: Antrodia camphorata; and a tea extract.

除非本文中另外定義,否則結合本發明使用之科技術語應具有一般技術者通常理解之含義。術語之含義及範疇應為明確的;然而,若存在任何潛在含糊性,則本文所提供之定義優先於任何詞典或外來定義。 Unless otherwise defined herein, the scientific terms used in connection with the present invention shall have the meaning commonly understood by one of ordinary skill. The meaning and scope of the terms should be clear; however, if there is any potential ambiguity, the definitions provided herein take precedence over any dictionary or foreign definition.

除非上下文另外需要,否則單數術語應包括複數,複數術語也應包括單數。 Unless the context requires otherwise, singular terms shall include the plural and plural terms shall also include the singular.

除非另外指示,否則應瞭解如本案所用之以下術語具有以下含義: Unless otherwise indicated, it should be understood that the following terms as used in this case have the following meanings:

本發明的範圍通常以「自一『約』特定數值及/或至另一『約』特定數值」表示。範圍可藉上述方式表示,若有包含自一特定數值及/或至另一特定數值之範圍,其便為另一實施例。同樣地,數值可藉由術語「約」以表示近似值,而當數值為一特定值,將可了解其為另一個實施例。依此也可了解當提及有關其它端點及其他端點本身而言,每一範圍的兩端點皆為有意義的。 The scope of the invention is generally indicated by the <RTI ID=0.0>" </ RTI> </ RTI> <RTIgt; Ranges may be expressed in the above-described manner, and if there is a range from a particular value and/or to another particular value, it is another embodiment. Similarly, a numerical value may be referred to by the term "about" to mean an approximation, and when the value is a particular value, it will be understood to be another embodiment. It can also be understood from this that when referring to other endpoints and other endpoints themselves, the endpoints of each range are meaningful.

「視情況」或「視情況地」係指隨後描述的事件或狀況可能會或可能不會發生,且該描述的事件或狀況包含或不包含例子。例如:詞組「視情況地包含藥劑」,表示該藥劑可能存在或不存在。 "As appropriate" or "as appropriate" means that the subsequently described event or condition may or may not occur, and that the described event or condition contains or does not include an example. For example, the phrase "optionally contains a medicament" means that the medicament may or may not be present.

如本文所用之術語「治療」表示減少及/或改善罹病個體之症狀。 The term "treating" as used herein means reducing and/or improving the symptoms of a rickety individual.

如本文所用之術語「個體」表示動物,特別是哺乳動物。根據本發明之較佳態樣,「個體」係指人類。 The term "individual" as used herein refers to an animal, particularly a mammal. According to a preferred aspect of the invention, "individual" refers to a human.

如本文所用之術語「治療有效量」表示一活性成分單獨或與其他治療/藥物合併使用時之用量,該用量足以顯示治療功效。 The term "therapeutically effective amount" as used herein means an amount of an active ingredient, either alone or in combination with other treatments/drugs, which is sufficient to demonstrate therapeutic efficacy.

如本文所用之術語「載劑」或「醫藥可接受之載劑」係指稀釋劑、賦形劑、接受體(acceptors)或類似物,其為製造醫藥組合物技術中之一般技術者所熟知。 The term "carrier" or "pharmaceutically acceptable carrier" as used herein refers to diluents, excipients, acceptors or the like which are well known to those of ordinary skill in the art of making pharmaceutical compositions. .

根據本發明之「牛樟芝」又稱為樟芝、牛樟菇,屬於擔子菌亞門、同擔子菌綱、無褶菌目、多孔菌科、薄孔菌屬,其學名可為Antrodia cinnamomeaGanoderma comphoratumAntrodia comphoratum;較佳係為Antrodia cinnamomea T.T.Chang & W.N.Chou。根據本發明之牛樟芝可為自然來源,例如台灣牛樟腐朽之心材內壁之菌株,或已經分離之菌株;另一方面,根據本發明之牛樟芝可為野生株或是經改良之突變株,亦可選用商業上可獲得之菌株。於本發明之較佳具體實施例中,該牛樟芝菌株係為中華民國台灣新竹食品工業發展研究所編號BCRC 930032、35396、35398、35716、36401、36711、36795、37848、37849或37850。 According to the present invention, "Bagba lucidum" is also known as Antrodia camphorata, and Astragalus membranaceus, belonging to the genus Basil, the genus Basidiomycetes, the genus Pleurotus, the Polyporaceae, and the genus Phaeocystis, and its scientific name may be Antrodia cinnamomea , Ganoderma. Comphoratum or Antrodia comphoratum ; preferably Antrodia cinnamomea TTChang & WNChou. The Antrodia camphorata according to the present invention may be a natural source, such as a strain of the inner wall of the heart of the Taiwanese burdock, or a strain that has been isolated; on the other hand, the Antrodia camphorata according to the present invention may be a wild strain or a modified mutant, Commercially available strains can be used. In a preferred embodiment of the present invention, the strain of Antrodia camphorata is the BCC 930032, 35396, 35398, 35716, 36401, 36611, 36795, 37848, 37849 or 37850 of the Hsinchu Food Industry Development Institute of the Republic of China.

根據本發明之「牛樟芝醱酵物」係指將前述牛樟芝培養或醱酵所得之培養物,其可包含牛樟芝菌株或去除牛樟芝菌株,該去除牛樟芝菌株之方法可為習知之滅菌方法;較佳地,該牛樟芝醱酵物係去除牛樟芝菌株。 According to the present invention, the method of cultivating or fermenting the aforementioned Antrodia camphorata may comprise a strain of Antrodia camphorata or a strain of Antrodia camphorata, and the method for removing the strain of Antrodia camphorata may be a conventional sterilization method; preferably, The Antrodia camphorata strain is used to remove the strain of Antrodia camphorata.

如本文所用之術語「滅菌」,係指殺死或除去物體上微生物及細菌芽孢之措施。本領域中常用之滅菌方法包含加壓滅菌法、紫外線照射滅菌法、過濾除菌法和化學藥劑滅菌法;較佳係為加壓滅菌法。加壓滅菌法一般係於密封之高壓蒸氣鍋中進行,使鍋中之蒸氣壓力上升到1.05公斤/平方厘米時,蒸汽溫度可達121℃,在此高溫下,連續約15分鐘以上,較佳為連續約15至120分鐘,更佳為約30至60分鐘,即可完成滅菌。 The term "sterilization" as used herein refers to a measure of killing or removing microorganisms and bacterial spores on an object. Sterilization methods commonly used in the art include a pressure sterilization method, an ultraviolet irradiation sterilization method, a filtration sterilization method, and a chemical sterilization method; preferably, a pressure sterilization method. The pressure sterilization method is generally carried out in a sealed high-pressure steam pot. When the vapor pressure in the pot is raised to 1.05 kg/cm 2 , the steam temperature can reach 121 ° C. At this high temperature, it is preferably about 15 minutes or more. Sterilization can be accomplished for about 15 to 120 minutes, more preferably about 30 to 60 minutes.

根據本發明用以牛樟芝醱酵之培養物或培養基係為可提供牛樟芝培養或醱酵所需能源者,其可為自然來源或人工合成之培養物或培養基,其自然來源例如台灣牛樟腐朽之心材內壁,較佳係為人工合成之培養物或培養基。 According to the present invention, the culture or culture medium for the fermentation of Antrodia camphorata can provide the energy required for the cultivation or fermentation of Antrodia camphorata, and it can be a natural source or a synthetic culture or a culture medium, and its natural source such as Taiwan beef calf decays. The inner wall of the heartwood is preferably a synthetic culture or culture medium.

根據本發明之人工合成培養基包含碳源、氮源及鹽類;其中碳 源為單糖及雙糖類或其混合物為主,單糖可以使用葡萄糖、果糖、半乳糖、甘露糖或其混合物;雙糖可以使用蔗糖、麥芽糖及乳糖或其混合物;其中氮源主要為複合式氮源,可以使用如酵母粉、酵母抽出物、大豆蛋白、牛肉腖或其混合物。鹽類包含鎂鹽及鉀鹽或其混合物。於本發明之較佳具體例中,碳源、氮源、鎂鹽及鉀鹽之比例為(約10至約30):(約1至約10):(約0.1至約2):(約0.1至約2)。 The synthetic medium according to the present invention comprises a carbon source, a nitrogen source, and a salt; wherein the carbon The source is monosaccharide and disaccharide or a mixture thereof, and the monosaccharide may use glucose, fructose, galactose, mannose or a mixture thereof; the disaccharide may use sucrose, maltose and lactose or a mixture thereof; wherein the nitrogen source is mainly composite As the nitrogen source, for example, yeast powder, yeast extract, soy protein, beef mash or a mixture thereof can be used. The salts include magnesium salts and potassium salts or mixtures thereof. In a preferred embodiment of the invention, the ratio of carbon source, nitrogen source, magnesium salt and potassium salt is (about 10 to about 30): (about 1 to about 10): (about 0.1 to about 2): (about 0.1 to about 2).

本發明所屬技術領域中具通常知識者可依本身之知識於約20℃至約35℃間選擇醱酵之溫度條件。於本發明之一較佳具體實施例中,該醱酵係為於約30℃下培養。另一方面,本發明所屬技術領域中具通常知識者可依本身之知識選擇醱酵之其他條件或醱酵型式,例如液態醱酵或固態醱酵;較佳地,該醱酵係為液態發酵。 Those of ordinary skill in the art to which the present invention pertains can select the temperature conditions for fermentation between about 20 ° C and about 35 ° C according to their knowledge. In a preferred embodiment of the invention, the fermentation is incubated at about 30 °C. On the other hand, those having ordinary knowledge in the technical field to which the present invention pertains may select other conditions or fermentation forms of fermentation, such as liquid fermentation or solid fermentation, according to their own knowledge; preferably, the fermentation is liquid fermentation. .

根據本發明之液態醱酵製程較佳係包含多階段之培養,於本發明之較佳具體例中,先以三角瓶轉速約50 rpm至約300 rpm培養約3天至約7天以製備種菌,再以50公升液態醱酵槽轉速約50 rpm至約500 rpm培養約3天至約7天,接著以500公升液態醱酵槽轉速約20 rpm至約150 rpm培養約3天至約7天,最後以5000公升液態醱酵槽轉速約10 rpm至約100 rpm培養約3天至約7天後提高轉速為約20 rpm至約100 rpm再培養約9天至約14天。 The liquid fermentation process according to the present invention preferably comprises a multi-stage culture. In a preferred embodiment of the present invention, the culture is carried out by cultivating the flask at a rotation speed of about 50 rpm to about 300 rpm for about 3 days to about 7 days. And culturing in a 50 liter liquid fermentation tank at a speed of about 50 rpm to about 500 rpm for about 3 days to about 7 days, followed by culturing at a flow rate of about 20 rpm to about 150 rpm for about 3 days to about 7 days in a 500 liter liquid fermentation tank. Finally, the culture is carried out at a temperature of about 10 rpm to about 100 rpm in about 5,000 liters of liquid fermentation tank for about 3 days to about 7 days, and then the rotation speed is from about 20 rpm to about 100 rpm for about 9 days to about 14 days.

根據本發明取得牛樟芝醱酵物之方法可為本發明所屬技術領域中具通常知識者視需要而可決定者,如採液態醱酵,可直接使用培養基或將培養基經處理後取得;如採固態醱酵,可以熱水或含甲醇、乙醇、丙二醇、異丙醇或乙酸乙酯之溶液萃取該經醱酵之培養基;較佳係為熱水或乙醇,並取其水溶性部份。該自固態培養基中獲得醱酵物之步驟可以任何習知方法實施,例如煎煮、浸泡、高溫高壓滅菌、超音波萃取法、攪拌、搖晃或其組合。 The method for obtaining the extract of Antrodia camphorata according to the present invention may be determined by those having ordinary knowledge in the technical field of the present invention, such as liquid fermentation, which may be directly used after the medium or the medium is treated; For fermenting, the fermented medium may be extracted with hot water or a solution containing methanol, ethanol, propylene glycol, isopropanol or ethyl acetate; preferably hot water or ethanol, and the water-soluble portion thereof is taken. The step of obtaining the mash from the solid medium can be carried out by any conventional method such as boiling, soaking, autoclaving, ultrasonic extraction, stirring, shaking, or a combination thereof.

根據本發明之牛樟芝醱酵物可視需要地自醱酵物中去除固體部 分之步驟,本發明所屬技術領域中具通常知識者可選擇合宜之去除條件,該等固體部分可由任何習知方法所移除,例如經由紗布過濾、離心或其組合;較佳係經由過濾或沉澱過濾去除。 The Astragalus membranaceus mash according to the present invention can be used to remove the solid part from the mash. In a sub-step, one of ordinary skill in the art can select suitable removal conditions that can be removed by any conventional method, such as by gauze filtration, centrifugation, or a combination thereof; Precipitation filtration removed.

根據本發明之牛樟芝醱酵物可視需要地濃縮,其可以任何習知方法濃縮該發酵物,例如冷凍乾燥或蒸發(J.Pharmacol.Sci.,99:294-300,2005及J.Chromatography,932:91-95,2001)以獲得經濃縮之醱酵萃取物,並可視需要加入賦形劑,例如甲基纖維素共同冷凍乾燥。 The Antrodia camphorata mash according to the present invention may be concentrated as needed, and the ferment may be concentrated by any conventional method such as freeze drying or evaporation (J. Pharmacol. Sci., 99: 294-300, 2005 and J. Chromatography, 932: 91-95, 2001) to obtain a concentrated leavek extract, and optionally freeze-dried by adding an excipient such as methyl cellulose.

於本發明之較佳實施例中,該牛樟芝醱酵物經高壓液相層析(High Pressure Liquid Chromatography,HPLC)分析,使用之層析管柱為Inersil ODS-2,5μm,(GL Sciences,ToKyo,Japan),該管柱之長度為250 mm,內徑為4.6 mm,使用之層析儀為Hitachi® PDA L2455,沖提液(A)為0.1%磷酸溶液,沖提液(B)為100%乙腈,沖提程式為0分鐘至60分鐘沖提液(A)由約90%降為約70%及沖提液(B)由約10%升為約30%;60分鐘至62分鐘:維持沖提液(A)為約70%及沖提液(B)為約30%;62分鐘至65分鐘沖提液(A)由約70%升為約90%及沖提液(B)由約30%降為約10%;65分鐘至80分鐘:維持沖提液(A)為約90%及沖提液(B)為約10%,其中於滯留時間約9.6、約11.0、約12.2、約15.5、約22.6、約28.8、約35.1、約49.6分鐘於波長220nm具有吸收峰。先前文獻已經初步確定了牛樟芝醱酵物之活性組成物(J Chilean Chemical Society.,52:1338-1340,2007),內含化合物1:2,3-Dimethoxy-5-methyl[1,4]benzoquinone、化合物2:2-Methoxy-6-methyl-1,4-benzoquinone、化合物3:5-Methyl-benzo[1,3]dioxole-4,7-dione、化合物4:5-Methyl-benzo[1,3]dioxole-4,7-diol等4種成份,此分析方法之吸收峰包含上述4種成份之1種或全部。 In a preferred embodiment of the invention, the Antrodia camphorata lysate is analyzed by High Pressure Liquid Chromatography (HPLC) using a chromatography column of Inersil ODS-2, 5 μm, (GL Sciences, ToKyo, Japan), the length of the column is 250 mm, the inner diameter is 4.6 mm, the chromatograph used is Hitachi® PDA L2455, the extract (A) is 0.1% phosphoric acid solution, and the extract (B) is 100%. Acetonitrile, the flushing formula is from 0 minutes to 60 minutes, the extract (A) is reduced from about 90% to about 70% and the extract (B) is raised from about 10% to about 30%; 60 minutes to 62 minutes: maintenance The extract (A) is about 70% and the extract (B) is about 30%; from 62 minutes to 65 minutes, the extract (A) is raised from about 70% to about 90% and the extract (B) is About 30% is reduced to about 10%; 65 minutes to 80 minutes: the extract (A) is about 90% and the extract (B) is about 10%, wherein the residence time is about 9.6, about 11.0, about 12.2. About 15.5, about 22.6, about 28.8, about 35.1, about 49.6 minutes have an absorption peak at a wavelength of 220 nm. The active composition of the extract of Antrodia camphorata (J Chilean Chemical Society., 52: 1338-1340, 2007) has been preliminarily identified in the literature, containing the compound 1:2,3-Dimethoxy-5-methyl[1,4]benzoquinone, Compound 2: 2-Methoxy-6-methyl-1,4-benzoquinone, Compound 3: 5-Methyl-benzo[1,3]dioxole-4,7-dione, Compound 4:5-Methyl-benzo[1,3 There are four components such as dioxole-4 and 7-diol. The absorption peak of this analytical method includes one or all of the above four components.

本發明所言之「茶葉」乙詞係指可用於泡茶的常綠灌木茶樹的葉或包含莖之葉;較佳為葉。依醱酵程度不同本發明之茶包含不醱酵 茶、半醱酵茶及全醱酵茶;較佳為全醱酵茶。依種類而言,該茶葉可包含綠茶、黃茶、白茶、青茶、黑茶或紅茶;較佳係為紅茶。 The term "tea" as used in the present invention refers to the leaves of the evergreen shrub tea tree or the leaves containing the stem which can be used for making tea; preferably leaves. The tea of the present invention contains no fermentation depending on the degree of fermentation. Tea, semi-fermented yeast tea and whole yeast tea; preferably whole yeast tea. Depending on the species, the tea leaves may comprise green tea, yellow tea, white tea, green tea, black tea or black tea; preferably black tea.

於本發明之一較佳具體實施例中,該茶葉係經乾燥處理。其乾燥之具體實施方式可為一般茶葉之乾燥方法,例如自然風乾、烘箱中乾燥或冷凍乾燥處理。 In a preferred embodiment of the invention, the tea leaves are dried. The specific embodiment of the drying may be a drying method of general tea leaves, such as natural air drying, drying in an oven or freeze drying.

於本發明之一較佳具體實施例中,該茶葉係經分離為碎片,以便利於萃取。其分離為碎片之具體實施方式可為一般茶葉之分離為碎片方法,例如切碎、剪碎、搗碎、研磨等方法。 In a preferred embodiment of the invention, the tea leaves are separated into pieces to facilitate extraction. The specific embodiment of the separation into fragments may be a method of separating the common tea leaves into pieces, such as chopping, shredding, chopping, grinding, and the like.

根據本發明之茶葉萃取物係將茶葉萃取而得,其步驟可為本發明所屬技術領域中具通常知識者視需要而可決定者,例如經冷凍萃取、水及/或水溶液萃取;較佳係為經水萃取。 The tea extract according to the present invention is obtained by extracting tea leaves, and the steps may be determined by those having ordinary knowledge in the art to which the present invention pertains, for example, by freeze extraction, water and/or aqueous extraction; For water extraction.

於本發明之一具體實施例中,該冷凍萃取之方法為一般之食品冷凍萃取法例如將根據本發明之組合物以急速凍結為固態,在適當真空的條件下使冰昇華為水蒸氣,獲得組合物之萃取物。於本發明之另一具體例中,包含以熱水或含甲醇、乙醇、丙二醇、異丙醇或乙酸乙酯之水溶液萃取該組合物;較佳係為熱水或乙醇,並取其水溶性部份。於本發明之一較佳具體實施例中,該甲醇、乙醇、丙二醇、異丙醇或乙酸乙酯液體為水溶液,其中濃度為約10至約100 v/v%;較佳者為約50至約90 v/v%;更佳者為約50至約80 v/v%;尤佳者為約50至約70 v/v%之溶液。 In a specific embodiment of the present invention, the method of freeze extraction is a general food freezing extraction method, for example, the composition according to the present invention is rapidly frozen into a solid state, and the ice is sublimated into water vapor under a suitable vacuum condition. An extract of the composition. In another embodiment of the present invention, the composition is extracted with hot water or an aqueous solution containing methanol, ethanol, propylene glycol, isopropanol or ethyl acetate; preferably hot water or ethanol, and water soluble Part. In a preferred embodiment of the invention, the methanol, ethanol, propylene glycol, isopropanol or ethyl acetate liquid is an aqueous solution having a concentration of from about 10 to about 100 v/v%; preferably about 50 to About 90 v/v%; more preferably from about 50 to about 80 v/v%; more preferably from about 50 to about 70 v/v% solution.

其萃取步驟如煎煮、浸泡、高溫高壓滅菌、超音波萃取法、攪拌、搖晃或其組合,較佳係為煎煮或浸泡。茶葉與水之萃取重量比例約1倍至約100倍;萃取時間為約30秒鐘至約24小時;較佳者為約1分鐘至約50分鐘;更佳者為約1分鐘至約30分鐘。萃取溫度為約0℃至約121℃、較佳者為約95℃至約121℃。 The extraction step such as boiling, soaking, autoclaving, ultrasonic extraction, stirring, shaking or a combination thereof is preferably decoction or soaking. The extraction weight ratio of tea leaves to water is from about 1 time to about 100 times; the extraction time is from about 30 seconds to about 24 hours; preferably from about 1 minute to about 50 minutes; more preferably from about 1 minute to about 30 minutes. . The extraction temperature is from about 0 ° C to about 121 ° C, preferably from about 95 ° C to about 121 ° C.

於本發明之一具體實施例中,該茶葉萃取物中去除固體部分之 步驟,本發明所屬技術領域中具通常知識者可選擇合宜之去除條件,該等固體部分可由任何習知方法所移除,例如經由紗布過濾、離心或其組合;較佳係經由過濾或沉澱過濾去除。 In a specific embodiment of the invention, the tea extract is removed from the solid portion Steps, one of ordinary skill in the art may select suitable removal conditions, which may be removed by any conventional method, such as by gauze filtration, centrifugation, or a combination thereof; preferably by filtration or precipitation filtration. Remove.

於本發明之較佳具體例中,根據本發明之組合物另包含植物萃取物,其中該植物萃取物係為薑科植物之根、莖部位萃取物;較佳為薑之根部萃取物。 In a preferred embodiment of the invention, the composition according to the invention further comprises a plant extract, wherein the plant extract is a root or stem extract of the family Zingiberaceae; preferably a root extract of ginger.

根據本發明之各成分可依需求調整其比例,較佳地,該牛樟芝醱酵物:茶葉萃取物之重量比為自約1:1至約1:20。如包含植物萃取物,該牛樟芝醱酵物:植物萃取物之重量比為自約10:1至約1:1。根據本發明之組合物其牛樟芝醱酵物及茶葉萃取物可分別製備再混合,亦可共同製備,較佳係分別製備再混合。 The components according to the present invention may be adjusted in proportion according to requirements. Preferably, the weight ratio of the Antrodia camphorata: tea extract is from about 1:1 to about 1:20. If the plant extract is included, the weight ratio of the Antrodia camphorata: plant extract is from about 10:1 to about 1:1. According to the composition of the present invention, the burdock mash and the tea extract can be prepared separately and mixed, or can be prepared together, preferably separately prepared and mixed.

於本發明之一較佳具體實施例中,該組合物係為食品組合物或醫藥組合物;於本發明之一更佳具體實施例中,該組合物係為食品組合物;於本發明之一尤佳具體實施例中,該組合物係作為飲品原料。 In a preferred embodiment of the present invention, the composition is a food composition or a pharmaceutical composition; in a further preferred embodiment of the present invention, the composition is a food composition; In a particularly preferred embodiment, the composition is used as a beverage raw material.

本發明組合物可藉由任何適當途徑投與至個體,例如口服投與。本發明組合物適當調配形式包括,但不限於錠劑、喉片、硬式或軟式膠囊、水性或油性懸浮液、乳劑、可分散粉末或顆粒、糖漿或酏劑(elixir)。如需要,可針對該組合物滅菌或與任何醫藥可接受之載劑,例如安定劑、濕化劑等混合。 The compositions of the invention may be administered to an individual by any suitable route, such as oral administration. Suitable formulations of the compositions of the present invention include, but are not limited to, lozenges, blister packs, hard or soft capsules, aqueous or oily suspensions, emulsions, dispersible powders or granules, syrups or elixirs. If desired, the composition can be sterilized or mixed with any pharmaceutically acceptable carrier, such as a stabilizer, a wetting agent, and the like.

本發明組合物可藉由任何習知方法與習知醫藥可接受之賦形劑予以混合。因此,欲用於口服之本發明組合物可包含,例如一或多種呈色劑、甜味劑、增味劑及/或保存劑。 The compositions of the present invention may be admixed by any conventional method with conventional pharmaceutically acceptable excipients. Thus, the compositions of the invention to be used orally may comprise, for example, one or more color formers, sweeteners, flavor enhancers, and/or preservatives.

本發明另提供一種前述組合物之用途,其係用於製備治療腫瘤之藥物。 The invention further provides the use of a composition as described above for the preparation of a medicament for the treatment of a tumor.

本發明亦提供一種前述組合物之用途,其係用於製備提升免疫力之藥物。 The invention also provides the use of a composition as described above for the preparation of a medicament for boosting immunity.

本發明所屬技術領域中具通常知識者當可無困難地選擇適當的投與途徑及劑量以進行治療需治療之個體。根據本發明,較佳途徑係口服投與。劑量則根據疾病之本質及其狀況、個體的年紀及健康狀況、投與途徑及前處理等情形而定出治療有效量。本發明所屬技術領域中具通常知識者當瞭解劑量會隨著個體的年紀、體重、健康狀況及其他相關因素而變化。 Those of ordinary skill in the art to which the present invention pertains can select the appropriate route of administration and dosage to treat the individual in need of treatment without difficulty. According to the invention, the preferred route is oral administration. The dose is determined according to the nature of the disease and its condition, the age and health of the individual, the route of administration and pretreatment. Those of ordinary skill in the art to which the invention pertains will appreciate that the dosage will vary with the age, weight, health, and other relevant factors of the individual.

上述實施例僅為說明本發明之原理及其功效,而非限制本發明。因此,習於此技術之人士對上述實施例所做之修改及變化仍不違背本發明之精神。本發明之權利範圍應如後述之申請專利範圍所列。 The above-described embodiments are merely illustrative of the principles and effects of the invention, and are not intended to limit the invention. Therefore, modifications and variations of the embodiments described above will be made without departing from the spirit of the invention. The scope of the invention should be as set forth in the appended claims.

實例Instance 牛樟芝醱酵物製備Preparation of burdock

將牛樟芝菌種BCRC 930032接種於含PDA之平板培養基上,於25℃恆溫箱中培養7天,再將生長良好之菌落以無菌水均質後,以培養基:菌液=9:1之比例接種至含PDB之三角瓶中,以25℃恆溫箱中轉速150 rpm震盪培養7天。再以此醱酵菌絲液以同比例接種至50公升液態醱酵槽中,以轉速50 rpm,通氣量0.2至0.3 v.v.m.,培養7天後接種至500公升液態醱酵槽中,以轉速20 rpm,通氣量0.2至0.3 v.v.m.,培養7天後接種至5000升液態醱酵槽以轉速20 rpm,通氣量0.1 v.v.m.,培養4天後改變轉速為50 rpm,以高轉速的剪切力使菌體產生壓力,誘導代謝物產生,再培養10至12天收槽。於液態醱酵之各階段溫度皆為30℃,培養基如上所述。培養完畢,經過濾後取得牛樟芝醱酵物。 The A. sinensis strain BCRC 930032 was inoculated on a PDA-containing plate medium, cultured in a 25 ° C incubator for 7 days, and the well-growth colonies were homogenized in sterile water, and then inoculated to a medium: bacterial solution = 9:1 ratio. The flask containing PDB was shaken for 7 days in a 25 ° C incubator at 150 rpm. Then, the fermented mycelium was inoculated into the 50-liter liquid fermentation tank in the same ratio at a rotation speed of 50 rpm and aeration of 0.2 to 0.3 vvm. After 7 days of culture, inoculate into a 500-liter liquid fermentation tank at a rotation speed of 20 Rpm, aeration of 0.2 to 0.3 vvm, cultured for 7 days, inoculated into a 5000 liter liquid fermentation tank at a speed of 20 rpm, aeration of 0.1 vvm, and after 4 days of culture, the rotational speed was changed to 50 rpm, and the bacteria were sterilized at a high rotational speed. The body produces pressure, induces metabolite production, and is cultured for another 10 to 12 days. The temperature was 30 ° C in each stage of liquid fermentation, and the medium was as described above. After the cultivation is completed, the sorghum sorghum mash is obtained by filtration.

茶葉萃取物製備Tea extract preparation

取紅茶葉依重量比1:10之比例與水混合後,加熱至沸騰進行萃取,時間為半小時,萃取終了將茶葉濾除,所得之濾液即為茶葉萃取物。 The black tea leaves are mixed with water according to the weight ratio of 1:10, and then heated to boiling for extraction for half an hour. After the extraction, the tea leaves are filtered out, and the obtained filtrate is a tea extract.

薑萃取物製備Ginger extract preparation

取栽植至10個月之老薑磨成泥後依重量比1:10之比例與水混合,加熱至沸騰進行萃取,時間為半小時,萃取終了將渣濾除,所得之濾液即為薑萃取物。 After being planted for 10 months, the ginger is ground into a mud and mixed with water at a weight ratio of 1:10. The mixture is heated to boiling for extraction for half an hour. After the extraction, the slag is filtered off, and the obtained filtrate is extracted by ginger. Things.

牛樟芝醱酵組合物Antrodia camphora fermentation broth

將例一中經離心所得之牛樟芝醱酵物、茶葉萃取物及薑萃取物依重量比3:3:1之比例充份混合即得牛樟芝醱酵組合物。 The boletus edulis fermented composition obtained by centrifugation in Example 1 was thoroughly mixed with a ratio of 3:3:1 by weight in a ratio of 3:3:1 by weight.

牛樟芝醱酵組合物功能性分析Functional analysis of the fermentation composition of Antrodia camphorata

利用量子共振圖譜檢測根據本發明之牛樟芝醱酵組合物之功能,量子共振圖譜為一種新興的快速、準確、無創波譜檢測方法,特別適用於保健食品療效對比的檢查,主要透過手握傳感器來收集人體微弱磁場的頻率和能量,經儀器放大、計算機處理後與儀器內部設計的營養指標的標準量子共振譜比較,用富利葉分析法分析樣品的波形,根據波形分析結果,對保健食品療效做出分析判斷,其已為廣泛接受之檢測方法,如Conf Proc IEEE Eng Med Biol Soc.即刊載一篇針對老鼠sacroma-180細胞動態監測之報導(Conf Proc IEEE Eng Med Biol Soc.,4:4119-22,2005),顯示QE values和免疫及抗腫瘤之能力具直接相關性。亦有相關之發明專利,如中華民國專利公告號第538351號。 The quantum resonance pattern is used to detect the function of the Antrodia camphorata fermentation composition according to the present invention. The quantum resonance spectrum is an emerging rapid, accurate and non-invasive spectrum detection method, and is particularly suitable for the examination of the contrast of health foods, mainly collected by hand sensors. The frequency and energy of the weak magnetic field of the human body are compared with the standard quantum resonance spectrum of the nutrient index designed by the instrument after being amplified by the instrument and processed by the computer. The waveform of the sample is analyzed by the Fourier analysis method, and the effect of the health food is made according to the waveform analysis result. Out of the analysis, it has been widely accepted, such as Conf Proc IEEE Eng Med Biol Soc., a report on the dynamic monitoring of mouse sacroma-180 cells (Conf Proc IEEE Eng Med Biol Soc., 4:4119- 22, 2005), showing that QE values are directly related to immunity and anti-tumor capabilities. There are also related invention patents, such as the Republic of China Patent Bulletin No. 538351.

將牛樟芝醱酵物、茶葉萃取物及薑萃取物依比例3:3:1之組合的飲料,利用量子共振圖譜檢測其療效,量子共振實驗結果顯示如下表1: The beverages of the combination of Astragalus membranaceus, tea extract and ginger extract in a ratio of 3:3:1 were measured by quantum resonance spectroscopy. The results of quantum resonance experiments are shown in Table 1:

(1)腫瘤訊息部份 (1) Tumor message part

若與單獨只有牛樟芝醱酵物的測試品相比,該牛樟芝醱酵物與紅茶萃取物依1:1比例混合之牛樟芝醱酵組合物,測試數值提高32%;若再添加薑萃取物,則數值提高64%。 If the test results are increased by 32% compared with the test sample in which only the burdock sorghum broth is mixed with the black tea extract in a ratio of 1:1, if the ginger extract is added, the value is increased. 64%.

(2)免疫功能部份 (2) Immune function part

若與單獨只有牛樟芝醱酵物的測試品相比,該牛樟芝醱酵物與茶葉萃取物依1:1比例混合之牛樟芝醱酵組合飲料,測試數值提高42%;若混合茶葉萃取物後再添加薑萃取物,則數值提高83%。 If the test results are increased by 42%, the test value is increased by 42% if the test mixture is mixed with the tea extract in a ratio of 1:1. If the tea extract is mixed, add ginger extract. The value of the object is increased by 83%.

Claims (10)

一種組合物,其包含:牛樟芝(Antrodia cinnamomea)醱酵物;及茶葉萃取物。 A composition comprising: Antrodia cinnamomea mash; and a tea extract. 根據請求項第1項之組合物,其中該牛樟芝醱酵物係由牛樟芝菌株醱酵而得,該牛樟芝菌株係選自由中華民國台灣新竹食品工業發展研究所編號BCRC 930032、35396、35398、35716、36401、36711、36795、37848、37849及37850所組成之群。 The composition according to claim 1, wherein the Astragalus membranaceus lysate is obtained by fermenting a strain of Antrodia camphorata, selected from the Hsinchu Food Industry Development Institute of the Republic of China, BCRC 930032, 35396, 35398, 35716, 36401 a group consisting of 36711, 36795, 37848, 37849 and 37850. 根據請求項第1項之組合物,其中該牛樟芝醱酵物經高壓液相層析(High Pressure Liquid Chromatography,HPLC)分析,使用之層析管柱為Inersil ODS-2,5μm,(GL Sciences,ToKyo,Japan),該管柱之長度為250 mm,內徑為4.6 mm,使用之層析儀為Hitachi® PDA L2455,沖提液(A)為0.1%磷酸溶液,沖提液(B)為100%乙腈,沖提程式為0分鐘至60分鐘沖提液(A)由約90%降為約70%及沖提液(B)由約10%升為約30%;60分鐘至62分鐘:維持沖提液(A)為約70%及沖提液(B)為約30%;62分鐘至65分鐘沖提液(A)由約70%升為約90%及沖提液(B)由約30%降為約10%;65分鐘至80分鐘:維持沖提液(A)為約90%及沖提液(B)為約10%;65分鐘至80分鐘:維持沖提液(A)90%,其中於滯留時間約9.6、約11.0、約12.2、約15.5、約22.6、約28.8、約35.1、約49.6分鐘於波長220nm具有吸收峰。 According to the composition of claim 1, wherein the Antrodia camphorata lysate is analyzed by High Pressure Liquid Chromatography (HPLC), and the chromatography column used is Inersil ODS-2, 5 μm, (GL Sciences, ToKyo , Japan), the length of the column is 250 mm, the inner diameter is 4.6 mm, the chromatograph used is Hitachi® PDA L2455, the extract (A) is 0.1% phosphoric acid solution, and the extract (B) is 100. % acetonitrile, the flushing formula is from 0 minutes to 60 minutes, the extract (A) is reduced from about 90% to about 70% and the extract (B) is raised from about 10% to about 30%; 60 minutes to 62 minutes: Maintaining the extract (A) is about 70% and the extract (B) is about 30%; from 62 minutes to 65 minutes, the extract (A) is raised from about 70% to about 90% and the extract (B) From about 30% to about 10%; 65 minutes to 80 minutes: maintain the extract (A) is about 90% and the extract (B) is about 10%; 65 minutes to 80 minutes: maintain the extract ( A) 90% with an absorption peak at a wavelength of 220 nm at a residence time of about 9.6, about 11.0, about 12.2, about 15.5, about 22.6, about 28.8, about 35.1, about 49.6 minutes. 根據請求項第1項之組合物,其中該茶葉萃取物係為全醱酵茶之萃取物。 The composition of claim 1, wherein the tea extract is an extract of whole yeast tea. 根據請求項第1項之組合物,其中該茶葉萃取物係為紅茶萃取物。 The composition of claim 1, wherein the tea extract is a black tea extract. 根據請求項第1項之組合物,其另包含植物萃取物,其中該植物萃取物係為薑萃取物。 The composition of claim 1, further comprising a plant extract, wherein the plant extract is a ginger extract. 根據請求項第1項之組合物,其中該牛樟芝醱酵物:茶葉萃取物之重量比為自約1:1至約1:20。 The composition of claim 1, wherein the weight ratio of the Antrodia camphorata: tea extract is from about 1:1 to about 1:20. 根據請求項第7項之組合物,其中該牛樟芝醱酵物:植物萃取物之重量比為自約10:1至約1:1。 The composition of claim 7, wherein the weight ratio of the Antrodia camphorata: plant extract is from about 10:1 to about 1:1. 一種根據請求項第1至8項任何一項之組合物之用途,其係用於製備治療腫瘤之藥物。 A use of a composition according to any one of claims 1 to 8 for the preparation of a medicament for treating a tumor. 一種根據請求項第1至8項任何一項之組合物之用途,其係用於製備提升免疫力之藥物。 A use of a composition according to any one of claims 1 to 8 for the preparation of a medicament for boosting immunity.
TW102115290A 2013-04-29 2013-04-29 Antrodia cinnamomea fermentation composition and uses thereof TW201440780A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW102115290A TW201440780A (en) 2013-04-29 2013-04-29 Antrodia cinnamomea fermentation composition and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW102115290A TW201440780A (en) 2013-04-29 2013-04-29 Antrodia cinnamomea fermentation composition and uses thereof

Publications (1)

Publication Number Publication Date
TW201440780A true TW201440780A (en) 2014-11-01

Family

ID=52422705

Family Applications (1)

Application Number Title Priority Date Filing Date
TW102115290A TW201440780A (en) 2013-04-29 2013-04-29 Antrodia cinnamomea fermentation composition and uses thereof

Country Status (1)

Country Link
TW (1) TW201440780A (en)

Similar Documents

Publication Publication Date Title
KR101252639B1 (en) Composition for Prevention or Treatment of Osteoporosis Comprising Ssanghwatang and Fermentation Product Thereof with Lactic Acid Bacteria
KR101339706B1 (en) A compound for immune strengthen inclusion reducing the bitterness of red ginseng, the extract of immune, and the probiotics
JP7471393B2 (en) Tea composition having preventive or ameliorative effects on respiratory diseases and pharmaceutical composition containing the same
KR101851195B1 (en) Fermented mulberry leaves, femented mulberry leaves extract and use there of
KR20090002677A (en) Cosmetic composition having antioxidation activity
KR102386296B1 (en) Complex-fermented composition of Fabaton soybean leaves and Schisandra chinensis having enhanced anti-diabetic and anti-obesity effects and preparation method thereof
CN106070779A (en) A kind of Chinese caterpillar fungus hypha fermentation tea and processing method thereof
KR20130011013A (en) Manufacturing methods of fermentation bellflower increased aneffective ingredient
KR101709281B1 (en) Composition for Prevention or Treatment of Osteoporosis Comprising Herbal Extract and Fermentation Product thereof with Lactic acid Bacteria
KR100340663B1 (en) A method of preparing the antitumor and immuno-activity polysaccharide from the artificial cultivation of inonotus obliquus, and its use
CN113893310A (en) Mountain plant fermentation composition and preparation method and application thereof
KR20110139472A (en) Composition for prevention or treatment of osteoporosis comprising bangpungtongseungsan and fermentation product thereof with lactic acid bacteria
KR102507651B1 (en) Fermented Stauntonia hexaphylla for hangover relief, alcoholic liver disease or liver function improvement using fermented enzyme complex solution containing traditional brewery yeast and its manufacturing method
KR20210027722A (en) Antimicrobial composition comprising the fermentation extract of medicinal or edible natural products
KR20120053564A (en) Fermented ginseng with ganoderma lucidum beverage manufacturing method and that beverage
KR102365480B1 (en) Manufacturing method of beverage composition for improving asthma, bronchitis or pneumonia comprising fermented extract of Aster tataricus as effective component
KR20180119940A (en) Method for extract of manufacturing fermentated tea and extract of fermentated tea prepared therefrom
KR101568823B1 (en) Composition containing an extract of vegetable worms containing germanium
TW201440780A (en) Antrodia cinnamomea fermentation composition and uses thereof
KR100650063B1 (en) a yeast manucture method by addition chinesemedicine ingredients
KR20100008220A (en) Composition for preventing and treating colon cancer containing extract of mushroom and herb medicine
KR100385658B1 (en) A grain culture composition of inonotus obliquus, a method of preparing the antitumor and immuno-activity polysaccharide from it and their use
KR20150037774A (en) Preparation of clove having enhanced antioxidative effect
KR101755338B1 (en) Process for preparation of grifola frondosa fruit body with twice fermentation and functional grifola frondosa fruit body fermentative products
KR20190084653A (en) Fermented Gastrodia eleata that improved taste and manufacturing method thereof